Ron DeLyons's most recent trade in Chemed Corp. was a trade of 277 Capital Stock done at an average price of $579.0 . Disclosure was reported to the exchange on May 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corp. | Ron DeLyons | Director | Grant, award, or other acquisition of securities at price $ 579.04 per share. | 19 May 2025 | 277 | 1,666 (0%) | 0% | 579.0 | 160,394 | Capital Stock |
| Chemed Corp. | Ron DeLyons | Director | Grant, award, or other acquisition of securities at price $ 564.34 per share. | 20 May 2024 | 284 | 1,389 (0%) | 0% | 564.3 | 160,273 | Capital Stock |
| Chemed Corp. | Ron DeLyons | Director | Grant, award, or other acquisition of securities at price $ 545.69 per share. | 15 May 2023 | 294 | 1,105 (0%) | 0% | 545.7 | 160,433 | capital stock |
| Chemed Corp. | Ron DeLyons | Director | Grant, award, or other acquisition of securities at price $ 496.25 per share. | 16 May 2022 | 262 | 811 (0%) | 0% | 496.3 | 130,018 | capital stock |
| Chemed Corp. | Ron DeLyons | Director | Grant, award, or other acquisition of securities at price $ 482.66 per share. | 17 May 2021 | 270 | 549 (0%) | 0% | 482.7 | 130,318 | capital stock |